Diabetic nephropathy is associated with gene expression levels of oxidative phosphorylation and related pathways

Diabetes

Volumn 55, Issue 6, 2006, Pages 1826-1831

  Huang, Chunmei ^a   Kim, Youngki ^a   Caramori, M Luiza ^a   Moore, Jason H ^b   Rich, Stephen S ^c   Mychaleckyj, Josyf C ^c   Walker, Paul C ^a   Mauer, Michael ^a,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d MMC 491 UMHC   (United States)

Author keywords

ROS, reactive oxygen species

Indexed keywords

PROSTAGLANDIN SYNTHASE;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST;

ADULT; CELLS, CULTURED; DIABETIC NEPHROPATHIES; ELECTRON TRANSPORT; FEMALE; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN; TRANSCRIPTION FACTORS;

EID: 33748308770     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db05-1438     Document Type: Article

References (27)

1. Betteridge DJ: What is oxidative stress? Metabolism 49 (2 Suppl. 1):3-8, 2000
2. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820, 2001
3. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348, 2001
4. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M: Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790, 2000
5. Kiritoshi S, Nishikawa T, Sonoda K, Kukidome D, Senokuchi T, Matsuo T, Matsumura T, Tokunaga H, Brownlee M, Araki E: Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes 52:2570-2577, 2003
6. Han HJ, Lee YJ, Park SH, Lee JH, Taub M: High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol 288:F988-F996, 2005
7. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005
8. DeRubertis FR, Craven PA, Melhem MF, Salah EM: Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 53:762-768, 2004
9. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC: Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170-2177, 2000
10. Chiarelli F, Di Marzio D, Santilli F, Mohn A, Blasetti A, Cipollone F, Mezzetti A, Verrotti A: Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy. Diabetes Care 28:1690-1697, 2005
11. Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M: Cellular basis of diabetic nephropathy. II. The transforming growth factor-beta system and diabetic nephropathy lesions in type 1 diabetes. Diabetes 51:3577-3581, 2002
12. Huang C, Kim Y, Caramori ML, Fish AJ, Rich SS, Miller ME, Russell GB, Mauer M: Cellular basis of diabetic nephropathy. III. In vitro GLUT1 mRNA expression and risk of diabetic nephropathy in type 1 diabetic patients. Diabetologia 47:1789-1794, 2004
13. Trevisan R, Li LK, Messent J, Tariq T, Earle K, Walker JD, Viberti G: Na+/H+ antiport activity and cell growth in cultured skin fibroblasts of IDDM patients with nephropathy. Diabetes 41:1239-1246, 1992
14. Trevisan R, Fioretto P, Barbosa J, Mauer M: Insulin-dependent diabetic sibling pairs are concordant for sodium-hydrogen antiport activity. Kidney Int 55:2383-2389, 1999
15. Iori E, Marescotti MC, Vedovato M, Ceolotto G, Avogaro A, Tiengo A, Del Prato S, Trevisan R: In situ protein kinase C activity is increased in cultured fibroblasts from type 1 diabetic patients with nephropathy. Diabetologia 46:524-530, 2003
16. Podesta F, Meregalli G, Ghelardi R, Del Giudice R, Asnaghi V, Maestroni A, Zerbini G: Low Ca(2+) pump activity in diabetic nephropathy. Am J Kidney Dis 38:465-472, 2001
17. Caramori ML, Kim Y, Huang C, Fish AJ, Rich SS, Miller ME, Russell G, Mauer M: Cellular basis of diabetic nephropathy. 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes. Diabetes 51:506-513, 2002
18. Affymetrix Microarray Suite User's Guide. Version 5.0. Santa Clara, CA, Affymetrix, 2001, p.412-415
19. Reif DM, Dudek SM, Schaffer CM, Wang J, Moore JH: Exploratory visual analysis of pharmacogenomic results. Pac Symb Biocomput 296-307, 2005
20. Reif DM, Moore JH: Visual analysis of statistical results from microarray studies of human breast cancer. Oncol Rep 15 (Spec. no.):1043-1047, 2006
21. Korshunov SS, Skulachev VP, Starkov AA: High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416:15-18, 1997
22. Roy S, Sala R, Cagliero E, Lorenzi M: Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A 87:404-408, 1990
23. Bergstrom G, Johansson I, Wickman A, Gan L, Thorup C: Brief losartan treatment in young spontaneously hypertensive rats abates long-term blood pressure elevation by effects on renal vascular structure. J Hypertens 20:1413-1421, 2002
24. Nagai Y, Yao L, Kobori H, Miyata K, Ozawa Y, Miyatake A, Yukimura T, Shokoji T, Kimura S, Kiyomoto H, Kohno M, Abe Y, Nishiyama A: Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 16:703-711, 2005
25. Soldner A, Spahn-Langguth H, Mutschler E: HPLC assays to simultaneously determine the angiotensin-AT1 antagonist losartan as well as its main and active metabolite EXP 3174 in biological material of humans and rats. J Pharm Biomed Anal 16:863-873, 1998
26. Lurbe A, Fioretto P, Mauer M, LaPointe MS, Batlle D: Growth phenotype of cultured skin fibroblasts from IDDM patients with and without nephropathy and overactivity of the Na+/H+ antiporter. Kidney Int 50:1684-1693, 1996
27. Ng LL, Davies JE, Siczkowski M, Sweeney FP, Quinn PA, Krolewski B, Krolewski AS: Abnormal Na+/H+ antiporter phenotype and turnover of immortalized lymphoblasts from type 1 diabetic patients with nephropathy. J Clin Invest 93:2750-2757, 1994